5 Heterosteroids and Drug Research (Q57382962)

1

0 references

Dharam Paul Jindal

2

0 references

Mange Ram Yadav

3

0 references

Manoj Kumar

Progress in medicinal chemistry

4

0 references

publication date

1991

0 references

published in

0 references

page(s)

233-300

0 references

cites work

2 Heterosteroids and Drug Research

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Brassinolide, a plant growth-promoting steroid isolated from Brassica napus pollen

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and biological activity of brassinolide and its 22β,23β-isomer: Novel plant growth-promoting steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of brassinosteroids and relationship of structure to plant growth-promoting effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Brassinosteroids and sterols from a green alga, Hydrodictyon reticulatum: Configuration at C-24

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Identification of 24-epibrassinolide in bee pollen of the broad bean, Vicia faba L.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies in terpenoid biosynthesis. Part 28. The acetate and mevalonate labelling patterns of the steroid, demethoxyviridin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies of terpenoid biosynthesis. Part 29. The cleavage of the sterol side chain in the biosynthesis of demethoxyviridin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies in terpenoid biosynthesis. Part 31. Some aspects of the chemistry and biosynthesis of the steroidal antibiotic, demethoxyviridin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Heterocyclic corticosteroids: I. Biological properties of the 6, 16α-dimethyl-4, 6-pregnadiene-11β, 17, 21-triol-20-one/ phenylpyrazole-21-acetate and its 21-desoxy derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Anti-inflammatory pyrazolo-steroids: Potent glucocorticoids containing bulky a-ring substituents and no C3-carbonyl

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Nivazol: a glucocorticoid in rats with only hypothalamic-pituitary-adrenal-inhibiting activity in primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The interaction of nivazol with the glucocorticoid receptor from rat and rhesus monkey target tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The effect of nivazol and cortivazol, novel synthetic steroids containing a phenylpyrazolo A-ring substitution, on blood pressure in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies on topical antiinflammatory corticosteroids. III. Synthesis and vasoconstrictive activity of 11 beta,17 alpha,21-trihydroxy-2'-phenyl-2'H-2,4-pregnadieno[3,2-c]pyrazol- 20-one derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Comparative study of deflazacort, a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and topical antiinflammatory activity of some steroidal [16 alpha, 17 alpha-d]Isoxazolidines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and structure-activity studies of corticosteroid 17-heterocyclic aromatic esters. 1. 9 alpha, 11 beta-dichloro series

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

17-Heteroaroyl esters of corticosteroids. 2. 11 beta-Hydroxy series

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies on topical antiinflammatory corticosteroids. II. Synthesis and vasoconstrictive activity of 11 beta,17 alpha,21-trihydroxy-6 alpha-methyl-1,4-pregnadiene-3,20-dione 17-methoxy- and (methylthio)acetates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Comparative pharmacokinetic studies of tixocortol pivalate and cortisol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies on topical antiinflammatory agents. II. Synthesis and vasoconstrictive activity of 21-substituted corticosteroids with sulfur-containing moieties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Anti-Inflammatory Steroids Without Pituitary-Adrenal Suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Anti-inflammatory activity of the epimers of N-propyl 20 xi-dihydroprednisolonamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of new antiinflammatory steroidal 20-carboxamides: (20R)- and (20S)-21-(N-substituted amino)-11 beta,17,20-trihydroxy-3,21-dioxo-1,4- pregnadiene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Binding of ester and amide epimers of 20 zeta-dihydroprednisolonic acid to cytosol receptors and their acute pharmacological activities in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and anti-inflammatory activity of steroidal 17-yl-.ALPHA.-oxothiocarboxamides and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and preliminary anti-inflammatory evaluation of 17beta-amino-3beta-methoxy-5-androstene hydrochloride and related derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and pharmacological evaluation of conjugates of prednisolone and non-steroidal anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

SC 25152: A Potent Mineralocorticoid Antagonist with Reduced Affinity for the 5α-Dihydrotestosterone Receptor of Human and Rat Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Determination of plasma levels of spirorenone, a new aldosterone antagonist, and one of its metabolites by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics of the new aldosterone antagonist, spirorenone, in healthy volunteers after single and repeated daily doses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Isolation and identification of spirorenone metabolites from the monkey (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Aldosterone antagonists. 1. Synthesis and activities of 6 beta,7 beta:15 beta,16 beta-dimethylene steroidal spirolactones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Aldosterone antagonists. 2. New 7 alpha-(acetylthio)-15,16-methylene spirolactones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

ZK91587: a novel synthetic antimineralocorticoid displays high affinity for corticosterone (type I) receptors in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Syntheses and biological activities of 7.beta.-methyl steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Apparent bioisosteric replacement of -S- by NCN: synthesis of N-cyano-2-aza-A-nor-5.alpha.-androstan-17.beta.-ol acetate, an aza steroid androgen

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Androgen receptor protein binding properties and tissue distribution of 2-selena-a-nor-5alpha-androstan-17beta-ol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of stanozolol on delta-aminolaevulinic acid synthase and hepatic monooxygenase activity in man and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Prodrugs utilizing organosilyl derivation: an investigation of the long-term androgenic and myotrophic activities of silyl derivatives of testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The antiprogestins: a recent advance in fertility regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Binding of the anti-progestin RU-486 to rat ovary steroid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Characterization of R 5020 and RU 486 binding to progesterone receptor from calf uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of the antiprogestin RU486 on progesterone production by cultured human granulosa cells: inhibition of the ovarian 3B-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of the antiprogestin RU486 on human ovarian steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Contraceptive potential of RU 486 by ovulation inhibition: II. Suppression of pituitary gonadotropin secretion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of the progesterone antagonist RU486 on ovarian activity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of RU 486 on luteal function in the early pregnant rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of egg development and implantation in rats after post-coital administration of the progesterone antagonist RU 486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of mifepristone (RU 486) on concentrations of prostaglandin E-2 binding sites in the rat endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

RU 486 completely inhibits the action of progesterone on cell proliferation in the mouse uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The effects of the progesterone antagonist RU-486 on mouse preimplantation development in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The effect of RU486 on transport, development and implantation of mouse embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies on the mechanisms of action of progesterone antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Day-night rhythm of 5-methoxytryptamine biosynthesis in the pineal gland of the golden hamster (Mesocricetus auratus)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Progesterone antagonist (RU 486) for cervical dilation, labor induction, and delivery in monkeys: effectiveness in combination with oxytocin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The effect of the anti-progestin RU 486 on early pregnancy in the long-tailed macaque (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Fertility control in women: results with RU 486 by the end of 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pregnancy termination with a high and medium dosage regimen of RU 486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Interception. IV: Failure of mifepristone (RU 486) as a monthly contragestive, "Lunarette"

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

1 reference

7 January 2021

Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Late postcoital treatment against pregnancy with antiprogesterone RU 486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Contragestion with late luteal administration of RU 486 (Mifepristone)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Why does RU486 fail to prevent implantation despite success in inducing menstruation?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pregnancy interruption with RU 486 in combination with dl-15-methyl-prostaglandin-F2 alpha-methyl ester: the Chinese experience

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Antagonistic action of RU38486 on the activity of transforming growth factor-β in fibroblasts and lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

RU486 inhibits induction of aromatase by dexamethasone via glucocorticoid receptor in cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Antiglucocorticoid properties of RU 38486 in a differentiated hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

An approach to the mechanism of the potent antiglucocorticoid: 17β-hydroxy- 11β -4-dimethylaminophenyl-17α- propynyl-estra-4,9-dien-3-one

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of progesterone, promegestone and RU 486 on glucocorticoid receptor levels in primary cultures of mouse mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of in vitro immunosuppressive effects of glucocorticosteroids by a competitive antagonist RU-486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Stimulation of specific transcription and DNA binding studies suggest that in vitro transformed RU 486-glucocorticosteroid receptor complexes display agonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of an antiglucocorticoid (RU-38486) on hydrocortisone induction of maltase-glucosamylase, sucrase-isomaltase and trehalase in brush border membranes of suckling rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Evidence for sex-dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Eye drops of RU 486-6, a peripheral steroid blocker, lower intraocular pressure in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

RU 486 inhibits peripheral effects of glucocorticoids in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Peripheral antiglucocorticoid action of RU 486 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Growth stimulation of T47D human breast cancer cells by the anti-progestin RU486.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Plasma concentrations and receptor binding of RU 486 and its metabolites in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics and metabolism of RU 486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics of the antiprogesterone RU 486 in women during multiple dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetic study of orally administered RU 486 in non-pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

New steroids with antiprogestational and antiglucocorticoid activities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of ENT-17-(prop-1-ynyl-17β-hydroxy-11β-(4-(N,N-dimethylamino) -phenyl)-4,9-estradien-3-one, the antipode of RU — 38 486

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of antiprogestational steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

3H-ZK 98,734, a new 11 beta-aryl substituted antigestagen: binding characteristics to receptor and serum proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Luteolytic action of two antiprogestational agents (RU-38486 and ZK-98734) in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Progesterone antagonist lilopristone: a potent abortifacient in the common marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Relative binding affinity of antiprogestins ZK 98.299 and ZK 98.734 for progesterone receptors in the endometrium and myometrium of bonnet monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Induction of menstruation by antiprogesterone ZK 98.299 in cycling bonnet monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

STEROIDAL HETEROCYCLES. VII. ANDROSTANO(2,3-D)ISOXAZOLES AND RELATED COMPOUNDS

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacology and pharmacokinetics of danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Review: The mechanism of action of danazol, a novel steroid derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazol: endocrine pharmacology and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazol has progestin-like actions on the human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The interaction of human endometrial and myometrial steroid receptors with danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Free testosterone levels during danazol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Buserelin versus danazol in the treatment of endometriosis-associated infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Prolactin and its response to the luteinizing hormone-releasing hormone thyrotropin-releasing hormone test in patients with endometriosis before, during, and after treatment with danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Gestrinone versus danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazol in the treatment of mammary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazole in the treatment of hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Hormone binding globulin levels in patients with hereditary angiooedema during treatment with Danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazol in the treatment of menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazol in the treatment of infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Danazol in the treatment of gynaecomastia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of new spiro-steroids, II: steroid-17-spiro-oxazolidinones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Novel 17.alpha.-chloro-17.beta.-sulfoxide steroids as specific inhibitors of sebaceous gland activity: potential antiacne agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and biological activity of some 15-oxaestranes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Conjugates of steroids and anti-cancer agents. III. The synthesis of estrynamine and certain derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and molecular structure of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-3-hydroxypropylamine; an amino-estrogen with prolonged anticoagulant and brief estrogenic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The anticoagulant effect of prolame, N-(3-hydroxy-1,3,5(10)estratrien-17 beta-yl)-3-hydroxypropylamine, a novel amino-estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Improved delivery through biological membranes. 32. Synthesis and biological activity of brain-targeted delivery systems for various estradiol derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Steroid binding to the cytosolic estrogen receptor from rat uterus. Influence of the orientation of substituents in the 17-position of the 8 beta- and 8 alpha-series

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Identification of thiol group at the estrogen-binding site on the cytoplasmic receptor from rabbit uterus by affinity labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Steroidal silicon side-chain analogues as potential antifertility agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Analogues of [(triethylsilyl)ethynyl]estradiol as potential antifertility agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Steroidal pure antioestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Novel antioestrogens without partial agonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Novel steroidal pure antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Biology and mode of action of pure antioestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and biological activity of 17 beta-substituted estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

STS 557 as an interceptive in rodents and baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Evaluation of STS-557 as a postcoital contraceptive in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of STS 557 on semen composition, fertility and sexual behaviour of male rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of male fertility by STS 557

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Evaluation of STS-557 as an oral contraceptive in male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Urinary metabolites of the new progestagen STS 557 (17 alpha-cyanomethyl-17-hydroxy-4,9-estradien-3-one) in the dog and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Biotransformation of norgestimate in women

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Disposition of ORF 9326, a novel contragestational steroid, in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Analysis of anti-implantational action of norethisterone-3-oxime

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of potential antiprogestins II.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Antispermatogenic/antiandrogenic properties of solasodine (C27H43O2N) obtained from solanum xanthocarpum berries on the male genital tract of dog (Canis-familiaris). A histophysiological approach

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

7 alpha-substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Covalent modification of aromatase by a radiolabeled irreversible inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Aromatase inhibitors and the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Aromatase inhibitors and their potential clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Aromatase inhibitors: basic and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and evaluation of 4-(substituted thio)-4-androstene-3,17-dione derivatives as potential aromatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Stereoselective inhibition of human placental aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The time-dependent inactivation of aromatase by 17β-hydroxy-10-methylthioestra-1,4-dien-3-one

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Thiol-containing androgens as suicide substrates of aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Interactions of thiol-containing androgens with human placental aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The effect of delta 1-testolactone on serum testosterone and estradiol in the adult male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Aromatase inhibitors and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Aromatase inhibitors: their biochemistry and clinical potential

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Response of Rat Ventral Prostate to a New and Novel 5αa-Reductase Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The inhibition of 3 beta HSD activity in porcine granulosa cells by 4-MA, a potent 5 alpha-reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Precopulatory behaviour in the male hamster: effect of the 5 alpha-reductase inhibitor 17 beta-N,N-diethylcarbamoyl-4-aza-5 alpha-androstan-3-one

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of a new 5 alpha-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Azasteroids as inhibitors of rat prostatic 5 alpha-reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Preparation of 20-(hydroxymethyl)-4-methyl-4-aza-2-oxa-5 alpha-pregnan-3-one as an inhibitor of testosterone 5 alpha-reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Prostatic effects induced in dogs by chronic or acute oral administration of 5 alpha-reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of testosterone 5 alpha-reductase by a proposed enzyme-activated, active site-directed inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacological induction of 5 alpha-reductase deficiency in the rat: separation of testosterone-mediated and 5 alpha-dihydrotestosterone-mediated effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Comparative studies of 5 alpha-reductase inhibitors within MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Trilostane, an orally active inhibitor of steroid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of Ovarian, Placental, and Adrenal Steroidogenesis in the Rhesus Monkey by Trilostane

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Potassium-sparing effect of trilostane in hydrochlorothiazide-treated rats and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of furosemide-induced kaliuresis in the rat by trilostane, an inhibitor of adrenal steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Primary aldosteronism: treatment with trilostane

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Primary aldosteronism treated by trilostane (3 beta-hydroxysteroid dehydrogenase inhibitor)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Experience with trilostane in the treatment of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of various adrenal inhibitors in low-renin essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Trilostane and the normal hypothalamic-pituitary-testicular axis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The inhibiting effect of trilostane on adrenal steroid synthesis: hormonal and morphological alterations induced by subchronic trilostane treatment in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies on the metabolism of trilostane, an inhibitor of adrenal steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Determination of trilostane and ketotrilostane in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

High-performance liquid chromatographic assay for trilostane and its major metabolite, 17-ketotrilostane, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The bioavailability and metabolism of trilostane in normal subjects, a comparative study using high pressure liquid chromatographic and quantitative cytochemical assays

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Steroidogenesis inhibitors. 1. Adrenal inhibitory and interceptive activity of trilostane and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Win 32,729, a new, potent interceptive agent in rats and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of ovulation in rats with epostane, an inhibitor of 3 beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of an inhibitor of 3 beta-hydroxysteroid dehydrogenase on progesterone concentrations and embryo survival in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of progesterone secretion by a 3 beta-hydroxysteroid dehydrogenase inhibitor in pregnant goats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of Epostane on progesterone synthesis in early human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in first- and second-trimester human pregnancy and the luteal phase using Epostane

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition of 3-beta-hydroxy steroid dehydrogenase activity in first trimester human pregnancy with trilostane and WIN 32729

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cardiac glycosides. 6. Gitoxigenin C16 acetates, formates, methoxycarbonates, and digitoxosides. Synthesis and Na+,K+-ATPase inhibitory activities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

In vivo and in vitro metabolism of gomphoside, a cardiotonic steroid with doubly-linked sugar

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and biological activity of some 3-amino compounds related to digoxigenin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and biological activity of some cardiotonic compounds related to digitoxigenin.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Inhibition by digoxin and SC4453 of (Na+ + K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The cardioactive properties of SC4453, a digoxin analogue with a C17β-pyridazine ring

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Prednisolone-3,20-bisguanylhydrazone: The mode of interaction with rat brain sosium and potassium-activated adenosine triphosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Prednisolone-3,20-bisguanylhydrazone: binding in vitro to sodium-and-potassium-activated adenosine triphosphatase of guinea pig heart ventricular muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cardenolide analogs. 7. Synthesis and biological activity of some new steroidal guanylhydrazones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cardenolide analogs. 9. Synthesis and biological activity of 17.beta.-carbomethoxyethylene and 17.beta.-cyanoethylene 14.alpha.-H steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

A new inotropic aminosteroid: LND 623

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Electrical and mechanical effects of new aminosteroids on guinea-pig isolated ventricular muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Ent-16 alpha-methylamino-3-methoxy-1,3,5(10)-estratrien-17 beta-ol hydrochloride, a selective anti-arrhytmic enantiosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Antiarrhythmic activity of 17 beta-aminoestratrienes. Comparison of 3-ols and 3-acetates with the corresponding 3-(3-amino-2-hydroxypropyl) ethers

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

A new series of steroidal antidysrhythmic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Electrophysiological and other effects on rabbit hearts of CCI22277, a new steroidal antiarrhythmic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cellular electrophysiological properties of a new aminosteroid antiarrhythmic agent, SC-35135

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The effect of oxandrolone on low and high density lipoprotein profiles in retired breeder rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of extended hypocholesterolemic drug treatment on peripheral and central nervous system sterol content of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Mechanism of cataract production by 3-β(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride, U18666A: An inhibitor of cholesterol biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Water-soluble steroidal anaesthetics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

A modification of the MGA 200 mass spectrometer to enable measurement of anaesthetic gas mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Early clinical evaluation of minaxolone: a new intravenous steroid anaesthetic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Minaxolone: a new water-soluble steroid anaesthetic

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Minaxolone, clinical effects and pharmacokinetics. Subanaesthetic infusion regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Development of a model for integrated pharmacokinetic and pharmacodynamic studies of intravenous anaesthetic agents: applications to minaxolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Regular and lasting neocortical spiking produced by systemic administration of a steroid derivative in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Antagonism of inhibitory amino acids by the steroid derivative RU5135

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects on gastric acid secretion of a steroidal alkaloid, epipachysamine-A, extracted from Pachysandra terminalis Sieb. et Zucc

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The emergence of ORG NC 45, 1- [2 beta,3 alpha,5 alpha,16 beta,17 beta)-3, 17-bis(acetyloxy)-2-(1-piperidinyl)-androstan-16-yl]-1-methylpiperidinium bromide, from the pancuronium series

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacology of Org NC 45 Compared with Other Nondepolarizing Neuromuscular Blocking Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Comparison of the Cardiovascular Actions of Org NC 45 with Those Produced By Other Non-Depolarizing Neuromuscular Blocking Agents in Experimental Animals

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Comparison of the neuromuscular blocking properties of ORG NC 45 and pancuronium in the rat, cat and rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The factors influencing the time course of drug action at alpha-adrenoceptors: an investigation of the effects of clonidine in the pithed rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Intradermal histamine releasing effect caused by Org-NC 45. A comparison with pancuronium, metocurine and d-tubocurarine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

First clinical experiences with ORG NC 45

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The Neuromuscular Blocking Action of ORG NC 45, A New Pancuronium Derivative, in Anaesthetized Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Experience with vecuronium during long-lasting surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Haemodynamic effects of vecuronium.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Bradycardia associated with the use of vecuronium. A comparative study with pancuronium with and without glycopyrronium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of clonidine on haemodynamic responses to endotracheal intubation and on gastric acidity.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Histamine release during the administration of atracurium or vecuronium in children

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics and Pharmacodynamics of ORG NC 45 in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Clinical pharmacokinetics of pancuronium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics and Pharmacodynamics of Vecuronium (ORG NC45) and Pancuronium in Anesthetized Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The use of different doses of vecuronium in patients with liver dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics and pharmacodynamics of vecuronium in patients with cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Distribution and kinetics of 14C-vecuronium in rats and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cardiovascular effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The neuromuscular and autonomic blocking effects of azasteroids containing choline or acetylcholine fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Total Synthesis of 1,11- and 3,11-Diazasteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Estramustine phosphate sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Specific binding of estramustine to prostatic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Spatial separation of the two essential thiol groups and the binding site of the exchangeable GTP in brain tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Selective delivery of cytotoxic compounds to cells by the LDL pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cholesterol ester formation by transesterification of chlorambucil: a novel pathway in drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Further studies on the antineoplastic activity of homo-aza-steroidal esters

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of a new nor-aza-steroidal ester of p-N,N-bis-(2-chloroethyl)aminophenylbutyric acid and in vitro study of its mutagenicity and clastogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

A new steroidal alkylating agent with improved activity in advanced murine leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxyacetate (NSC 294859) on experimental animal tumor and leukemia systems

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstane-17-oic-13,17-lactam(p-(bis(2-chloroethyl)amino)-phenyl) acetate(NSC 290205) in murine solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Further studies on the anti-neoplastic activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [p-[bis(2-chloroethyl)amino]-phenyl]acetate (NSC 290205)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of steroidal nitrosoureas with antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of butylated hydroxyanisole on glutathione S-transferase and catechol O- methyltransferase activities in syrian golden hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

New steroidal nitrosoureas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Boron estrogens: synthesis, biochemical and biological testing of estrone and estradiol-17 beta 3-carboranylmethyl ethers

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

3,17 beta-Dihydroxy-20,21-epoxy-19-norpregna-1,3,5(10)-trienes: synthesis, rearrangement, cytotoxicity, and estrogen-receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of some analogs of estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Some adenine and adenosine methylene-bridged estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

In vitro inhibition of estrogen sulfoconjugation by some 2- and 4-substituted estra-1,3,5(10)-trien-17 beta-ols1a

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and evaluation of novel N-substituted N'-(3-hydroxy-17-oxoestra-1,3,5(10)-trien-2- and -4-yl)thiourea derivatives for binding to the estrogen receptor and cytotoxic activity on MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The structures of two potential antitumor steroid--base adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Nucleoside conjugates as potential antitumor agents. 2. Synthesis and biological activity of 1-.beta.-D-arabinofuranosylcytosine conjugates of prednisolone and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Nucleoside conjugates V: Synthesis and biological activity of 9-(beta-D-arabinofuranosyl)adenine conjugates of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

α-Methylene-γ-lactone fused to steroidal ring d as potential antitumor agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Steroidal alpha-methylene delta-lactones as potential antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and cytotoxic activity of estrogen alpha-methylene-delta-lactones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006F

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of the 21-aminosteroid U74006F on experimental head injury in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of pregnenolone--16 alpha-carbonitrile (PCN) on bilirubin clearance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Reduction by acetylsalicylic acid of paracetamol-induced hepatic glutathione depletion in rats treated with 4,4'-dichlorobiphenyl, phenobarbitone and pregnenolone-16-alpha-carbonitrile

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Iodine-125—Labeled Estradiol: a Gamma-Emitting Analog of Estradiol That Binds to the Estrogen Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Interaction of 16 alpha-[125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Assay of estradiol receptors in human breast carcinomas using the gamma emitting ligand 16 alpha [125I]iodoestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The molecular structure of 16 alpha-iodo-17 beta-estradiol, a high affinity ligand for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and evaluation of potential radioligands for the progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

E-17 alpha-(2-[125I]iodovinyl)-19-nortestosterone: the synthesis of a gamma-emitting ligand for the progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Selenium labeling in nuclear medicine. 2. D ring substituted estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and biochemical screening of phenylselenium-substituted steroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

A radioimmunoassay for deoxycorticosterone sulfate without hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of 11 alpha-hydroxyprogesterone haptens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Development and application of a radioimmunoassay for 2-hydroxyestriol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of new steroid haptens for radioimmunoassay—VI. 3-O-carboxymethyl ether derivatives of equine estrogens. Highly specific antisera for measurement of equilin and 17α-dihydroequilin in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The preparation of amino bile acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis and photochemical reactions of nitroestrogens: possible photoaffinity labels of zero length

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Synthesis of photoaffinity analogs of progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effects of Fildes Enrichment on Antibiotic Susceptibility Testing of Haemophilus influenzae in the Autobac

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Antifungal properties of solanum alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Steroidal saponins from elephant garlic, bulbs of Allium ampeloprasum L.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

The preparation of bile acid amides and oxazolines. II. The synthesis of the amides and oxazolines of ursodeoxycholic acid, deoxycholic acid, hyodeoxycholic acid and cholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Rhinovirus inhibition by bufadienolides.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Chonemorphine, stigmasterol, and ecdysterone: steroids isolated through bioassay-directed plant screening programs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Chonemorphine and rapanone--antiparasitic agents from plant sources

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Antiamoebic activity of chonemorphine, a steroidal alkaloid, in experimental models

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Soft drugs V: Thiazolidine-type derivatives of progesterone and testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Functional cholesteryl binding agents: synthesis, characterization, and evaluation of antibody binding to modified phospholipid vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Studies on the glucocorticoid-receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumour cells and normal rat pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacodynamics of the antiprogesterone RU486 in women after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Endocrine Properties and Clinical Application of Danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Effect of org 6001 on reperfusion dysrhythmias and lactate dehydrogenase release in isolated rat hearts: comparison with propranolol and lignocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021

Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970366-7

7 January 2021